← back to search

Lin Zhang

Anhui University of Technology · CN
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, RNA modifications and cancer, and Cell death mechanisms and regulation.
h-index
100
citations
57,281
works
1,298
NIH funding
primary concept
email

Recent publications

Reactivating necroptosis in colorectal cancer potentiates chemotherapy and antitumor immune responses.
2026cited by 0position: contributordoi
Depletion of oxysterol-binding proteins by OSW-1 triggers RIP1/RIP3-independent necroptosis and sensitization to cancer immunotherapy.
2025cited by 7position: contributordoi
PD-1 suppression enhances HIV reactivation and T-cell immunity via MAPK/NF-κB signaling
European journal of medical research 2025cited by 7position: middledoi
Understanding the Functional Dependence and Inhibition of the Bcl-2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine
ACS Pharmacology & Translational Science 2025cited by 3position: middledoi
Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma
ImmunoTargets and Therapy 2025cited by 3position: middledoi
Nutrient-mediated changes in growth, biochemical composition, and biosilica deposition in Cyclotella cryptica
Journal of Oceanology and Limnology 2025cited by 3position: middledoi
Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer.
2025cited by 2position: contributordoi
Differential Response and Resistance to KRAS-Targeted Therapy.
2025cited by 2position: contributordoi
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes.
2025cited by 2position: contributordoi
Low extracellular pH enhances TRAIL-induced apoptosis by downregulating Mcl-1 expression.
2025cited by 1position: contributordoi
Mcl-1 is a Gatekeeper Molecule to Regulate the Crosstalk Between Ferroptotic Agent-Induced ER Stress and TRAIL-Induced Apoptosis.
2025cited by 1position: contributordoi
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer.
2025cited by 1position: contributordoi
Correction: eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis
eLife 2025cited by 0position: contributordoi
Identification of CAV1 and CDH5 as potential diagnostic and prognostic biomarkers in lung adenocarcinoma
Experimental and Therapeutic Medicine 2025cited by 0position: firstdoi
Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects
Metabolism 2024cited by 48position: middledoi
NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma
Cancer Science 2024cited by 20position: middledoi
PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer.
2024cited by 12position: contributordoi
Wild imitating vs greenhouse cultivated Dendrobium huoshanense: Chemical quality differences
PLoS ONE 2024cited by 11position: middledoi
Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer.
2024cited by 8position: contributordoi
UNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples.
2024cited by 8position: contributordoi
Effects of salinity and temperature on growth performance, biochemical composition, and biosilification process of Cyclotella cryptica
Algal Research 2024cited by 7position: middledoi
Effect of CHST11, a novel biomarker, on the biological functionalities of clear cell renal cell carcinoma
Scientific Reports 2024cited by 4position: middledoi
Figure S2 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Data from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Figure S4 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Figure S4 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Figure S1 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Figure S6 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Figure S8 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi
Table S1 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 51 papers (2020–2026)Jian Yu · University of Southern California43 papers (2020–2025)Kaylee Ermine · University of Pittsburgh31 papers (2022–2024)Xinyan Lu · University of Southern California26 papers (2024–2026) · 26 papers (2024–2025)Donna B. Stolz · University of Pittsburgh Medical Center26 papers (2020–2024) · 25 papers (2024–2024)Peng Wang · Icahn School of Medicine at Mount Sinai25 papers (2024–2024)Xiaojun Chen · UPMC Hillman Cancer Center25 papers (2024–2024)Yi-Jun Wang · Ono Pharmaceutical (United States)25 papers (2024–2024)Denise Risnik · Consejo Nacional de Investigaciones Científicas y Técnicas8 papers (2021–2023)Xiangping Song · University of Pittsburgh5 papers (2022–2023)Li Hu · Guangzhou University of Chinese Medicine4 papers (2022–2024)Robert E. Schoen · Pennsylvania State University4 papers (2019–2026)Gang Wei · Guangzhou University of Chinese Medicine4 papers (2022–2024)Yuechun Huang · Guangzhou University of Chinese Medicine4 papers (2022–2024)Yuanjun Meng · Guangzhou University of Chinese Medicine4 papers (2022–2024)Miao‐Zhen Qiu · Sun Yat-sen University4 papers (2015–2020)Yuhang Li · University of Illinois Urbana-Champaign3 papers (2023–2025)Xianglei Yan · Karolinska University Hospital3 papers (2018–2020)